ESTEATOSIS HEPÁTICA NO ALCOHÓLICA: RELACIÓN CON LA CIRCUNFERENCIA DE CINTURA
Resumen
Introducción: La esteatosis hepática no alcohólica ocurre cuando la grasa se deposita en el hígado y la obesidad es considerada uno de los factores relacionados en la aparición de esta patología, debido a que se ha observado que es una condición esteato inflamatoria que ocurre sólo en el 2,5% de la población no obesa. La circunferencia de cintura es una medición antropométrica relacionada con adiposidad visceral, y es muy utilizada por su capacidad de identificar el riesgo de padecer algunas enfermedades metabólicas y cardiovasculares. El Objetivo es relacionar la circunferencia de cintura con la presencia de esteatosis hepática no alcohólica determinado por ultrasonido abdominal. Pacientes y Métodos: Se determinó la circunferencia de cintura mediante la medición según la técnica de Lohman, Roche y Martorell, y se comparó con los resultados de un ultrasonido abdominal en tiempo real para la determinación de EHNA. Resultados: en todos los pacientes, a medida que existe mayor severidad en el diagnóstico de esteatosis hepática no alcohólica, la circunferencia de cintura es mayor. Conclusiones: la elevación de la circunferencia de cintura se relaciona directa y significativamente con la aparición de esteatosis hepática no alcohólica.
ESCUCHAR RESUMEN DEL ARTICULOPalabras clave
Texto completo:
PDFReferencias
WHO Global health risks: Mortality and burden of disease attributable to selected major risks. Technical report, World Health Organization. 2009 URL http://www.who.int/entity/healthinfo/global_burden_disease/GlobalHealthRisks_report_full.pdf
Nayak N, Vasdev S, Saigal, Soin, A. S. End stage nonalcoholic fatty liver disease: evaluation of pathomorphologic features and relationship to cryptogenic cirrhosis from study of explant livers in a living donor liver transplant program. Hum Pathol. 2010; 41 (3):425–30.
Montes de Oca I. Obesidad y la esteatohepatitis no alcohólica (EHNA): Su interrelación y estudio. Acta Med Colomb. 2007; 32(3):185-86.
Ratziu V, Bellentani S, Cortez-Pinto H, C. Day, Marchesini G. A position statement on NAFLD/NASH based on the EASL 2009 special conference. Journal of Hepatology. 2010; 53 (2): 372–84.
Anand S. S, Yusuf S. Stemming the global tsunami of cardiovascular disease .The Lancet. 2011; 377 (9765): 529–32.
Van Der Poorten D, Milner KL, Hui J, Hodge A, Trenell MI, Kench JG, et al. Visceral Fat: A Key Mediator of Steatohepatitis in Metabolic Liver Disease, Hepatology, Vol. 48, No. 2, 2008.
Zhu S, Wang Z, Heshka S, Heo M, Faith M., Heymsfield S. Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: clinical action thresholds. Am J Clin Nutr 2002; 76: 743–9.
National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults – the Evidence Report. NIH Publication No. 98-4083 September 1998.
Han T, van Leer E, Seidell J, Lean M. Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ 1995; 311: 1401-5.
Wang J, Thornton J, Bari S, Williamson B, Gallagher D, Heymsfield S, et al. Comparisons of waist circumferences measured at 4 sites. Am J Clin Nutr 2003; 77: 379–84.
Pounder D, Carson D, Davison M, Orihara Y. Evaluation of indices of obesity in men: descriptive study. BMJ 1998; 316: 1428-9.
Wang J. Waist circumference: a simple, inexpensive, and reliable tool that should be included as part of physical examinations in the doctor’s office. Am J Clin Nutr. 2003; 78:902–3.
Ross R, Katzmarzyk PT. Cardiorespiratory fitness is associated with diminished total and abdominal obesity independent of body mass index. Int J Obes Relat Metab Disord. 2003; 27:204-10.
Macias MA, Rendon P, Herrera LM. Valoración ultrasonografía del estadio de la hepatopatía crónica. Servicio de Aparato Digestivo. Hospital Puerta del Mar. Cádiz, May 2006.
Janssen I, Heymsfield SB, Allison DB, Kotler DP and Ross R. Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal subcutaneous, and visceral fat. Am J Clin Nutr 2002; 75:683–8
Chen SH, He F, Zhou HL, Wu HR, Xia C, Li YM. Relationship between nonalcoholic fatty liver disease and metabolic syndrome. J Dig Dis. 2011; 12(2):125-30.
Wang CC, Tseng TC, Hsieh TC, Hsu CS, Wang PC, Lin HH, Kao JH. Severity of fatty liver on ultrasound correlates with metabolic and cardiovascular risk. Kaohsiung J Med Sci. 2012; 28(3):151-60.
Rui-Dan Zheng, Zhuo-Ran Chen, Jian-Neng Chen, Yan-Hui Lu, Jie Chen. Role of BodyMass Index,Waist-to-Height andWaist-to-Hip Ratio in Prediction of Nonalcoholic Fatty Liver Disease. Gastroenterology Research and Practice. Volumen 2012. 6 páginas.
Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology. 2005; 42(1):44-52.
Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Anna Castiglione A, et al.The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterology 2006, 6:33
Medina Santander CE; Gómez A, Pérez H; Gómez C. Insulinorresistencia en pacientes con esteatosis hepática. Med. Fam. (Caracas). 2005; 13(2):21-26.
Wanderlinder J, Domínguez M, León R, Ruiz M, Beker B, Golindano C, et al. Aspectos epidemiológicos, clínicos e histológicos de enfermedad hepática grasa no alcohólica en pacientes venezolanos. GEN.2003; 57:5-11.
A-Kader HH. Nonalcoholic fatty liver disease in children living in the obeseogenic society. World J Pediatr 2009; 5:245-254.
Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The Diagnosis and Management of Non-Alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association Hepatology, Vol. 55, No. 6, 2012.
Hubscher SG. Histological assessment of nonalcoholic fatty liver disease. Histopathology 2006; 49:450-465.
Aschner P, Buendía R, Brajkovichb I, Gonzales A, Figueredo R, Juares X et al. Determination of the cutoff pointfor waist circumference that establishes the presence of abdominal obesity in Latin American men and women. Diabetes Research and clinical practice 93 (2011) 243-247.
Camacho N, Guillén M, Gil G†, Paoli M, Molina Z, Cicchetti R, et al. Esteatosis hepática en niños y adolescentes obesos: asociados con adiposidad, lípidos, insulina y enzimas hepáticas. Rev Venez Endocrinol Metab 2010; 8(1): 19-29
Charatcharoenwitthaya PP, Lindor KD. Role of radiologic modalities in the management of non-alcoholic steatohepatitis. Clin Liver Dis. 2007 11:37–54
Torres DM, Harrison SA. Diagnosis and Therapy of Nonalcoholic Steatohepatitis. Gastroenterology. 2008; 134:1682–1698
WHO. Waist Circumference and Waist–Hip Ratio:Report of a WHO Expert Consultation Geneva, December 2008; 8–11.
Neuschwander- Tetri BA, Caldwell SH. Nonacoholic steatohepatitis: Summary of an AASLD Single Topic Conference. Hepatology 2003; 37:1202-1219.
Bedogni, Belletoni S. Fatty liver: How frecuent is it and why? Ann Hepatol 2004; 3:63-65.
Karavia E, Papachristou D, Liopeta K, Triantaphyllidou I,Dimitrakopoulos O, Kypreos K. Apolipoprotein A-I Modulates Processes Associated with Diet-Induced Nonalcoholic Fatty Liver Disease in Mice. Mol Med 1 8: 901 - 9 1 2, 2012.
Naomi A, Sumihisa H and Doosub J. Cut-off Values as a Marker for Fatty Liver among Japanese Workers.Saf Health Work. 2012; 3:287-93.
Encuesta Nacional de Consumo de Alimentos Tercera prueba piloto. Boletín Informativo. Instituto Nacional de Estadística. Abril Junio 2012.
Bedogni G, Miglioli M, Massuti F, Tiribelli C, Marchesini M. Prevalence of and Risk Factors for Nonalcoholic Fatty Liver Disease: The Dionysos Nutrition and Liver Study.Hepatology 2005; 42:44-52.
Belletani S. Scaglioni F, Marino M, Bedogni G. Epidemiology of Non-Alcoholic Fatty Liver Disease. Dig Dis 2010; 28:155-161.
Falck-Ytter Y, Younossi ZM, Marchesini G, McCullough AJ. Clinical Features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis 2001; 21:17-26.
Shahinul A, Sheikh M, Ziaur C, Mahabubul A, Jahangir K. Nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients of Bangladesh.World J Hepatol 2013 May 27; 5(5): 281-287.
Xiaona H, Yiqin H, Zhijun B, Yiqian W, Dongmei S, Fang L, et al. Prevalence and factors associated with nonalcoholic fatty liver disease in shanghai work-units. BMC Gastroenterology 2012, 12:123
Perini T, De Oliveira G, Dos Santos J, De Olivera F. Technical error of measurement in anthropometry. Rev Bras Med Esporte. Vol. 11, Nº 1 – Jan/Fev, 2005
DOI: http://dx.doi.org/10.61155/gen.v71i2.347
VIDEOS GEN
Autor: Dr. Freddy Pereira Graterol
 |  |  |
CPRE. Sitio de sección del ducto pancreático principal | Drenaje transgástrico de pseudoquiste pancreático | CPRE. Sección del ducto hepático izquierdo por traumatismo de abdomen |
Autora: Dra. Anais Karina García Yaraure
 |  | |
Cavernomatosis portal Pre Colocacion de TIPS. | Cavernomatosis portal Post Colocacion de TIPS. |
 |  |  |
Revista GEN
ISSN: 0016-3503 e-ISSN: 2477-975X